BioAge Labs, Inc
BIOA
$5.62-5.47%
Delayed · as of Oct 13, 2026, 11:45 AM ET
Mkt cap
$697.91M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$8.99M
EPS (TTM)
$-2.39
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-896.11%
Beta
N/A
Div yield
N/A
Sector
Healthcare
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Use this BIOA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BIOA income, balance, and cash tables.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached BioAge Labs, Inc (BIOA) revenue for Dec 31, 2025 was $9.0M. Net income was -$80.6M. Statements: https://lician.com/financials/bioa
BioAge Labs, Inc (BIOA) market capitalization is $697.9M on the latest cached snapshot.
BioAge Labs, Inc (BIOA) cached previous close $5.94; day range $5.62 – $5.90; volume 134,962. Session quote: https://lician.com/quote/bioa
BioAge Labs, Inc (BIOA) latest cached earnings event is "BIOA earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BIOA filing is 8-K · Oct 2, 2026. Filings: https://lician.com/sec/bioa